Technology Profile
| Title: | Phytopharmaceutical Lead for the Management of Cancer Pain |
| Value Proposition: | The proposed CBD-THC-based phytopharmaceutical lead, demonstrates potent efficacy in a mouse model of chemotherapy-induced neuropathic pain. Its therapeutic potential is driven by the pharmacological activity of its key chemical markers, CBD and THC, which modulate CB1/CB2 receptors and exert strong anti-inflammatory effects. |
| Summary Application: | For the managment of cancer pain. |
| Advantages: | CBD/THC based formulation derived from medical cannabis, to be used in the management of cancer pain. |
| Tech. Readiness Level: |
CSIR-Indian Institute of Integrative Medicine[CSIR-IIIM]
: director[at]iiim[dot]res[dot]in
:91-191-2585222
:https://iiim.res.in
: director[at]iiim[dot]res[dot]in
:91-191-2585222
:https://iiim.res.in
Industrial Applications:
Formulations [Drugs and Pharmaceuticals]
Patent Application(s):
WO2023223351